BAP1 and neoplasm: The inactivation of BAP1 leads to poor cell cycle regulation and cell proliferation, resulting in tumorigenesis, characterizing a clinically unique subtype of ccRCC, marked by aggressive characteristics and an inflammatory but immunosuppressed tumor microenvironment [33,34].